BRCA1-mutant breast tumors are typically estrogen receptor alpha (ER{alpha}) negative, whereas most sporadic tumors express wild-type BRCA1 and are ER{alpha} positive. We examined a possible mechanism for the observed ER{alpha}-negative phenotype of BRCA1-mutant tumors.